Related Experiment Videos
Cathepsin S inhibitors as novel immunomodulators
Robin L Thurmond1, Siquan Sun, Lars Karlsson
1Johnson & Johnson Pharmaceutical Research & Development LLC, San Diego, CA 92121, USA. rthurmon@prdus.jnj.com
Current Opinion in Investigational Drugs (London, England : 2000)
|May 26, 2005
Summary
Cathepsin S, a cysteine protease, is vital for antigen presentation by immune cells. Inhibiting Cathepsin S offers a promising therapeutic strategy for various diseases like arthritis and atherosclerosis.
Area of Science:
- Immunology
- Protease biochemistry
Background:
- Cathepsin S is a key cysteine protease found in lysosomes of antigen-presenting cells.
- It plays a critical role in processing invariant chain molecules for MHC class II-mediated antigen presentation.
- It is also involved in antigen processing for MHC class I cross-presentation.
Purpose of the Study:
- To elucidate the multifaceted roles of Cathepsin S in antigen presentation.
- To explore the potential of Cathepsin S as a therapeutic target for immune-related diseases.
Main Methods:
- Analysis of Cathepsin S expression and localization in antigen-presenting cells.
- Investigation of Cathepsin S enzymatic activity in antigen processing pathways.
- Review of existing literature on Cathepsin S involvement in extracellular matrix degradation and disease pathology.
Main Results:
- Cathepsin S is essential for efficient antigen presentation to CD4+ T-cells and NK1.1+ T-cells.
- It participates in both direct and cross-presentation of antigens.
- Secreted Cathepsin S may contribute to extracellular matrix degradation, implicating it in diseases such as arthritis and atherosclerosis.
Conclusions:
- Cathepsin S is a crucial enzyme in adaptive and innate immune responses.
- Its inhibition represents a promising therapeutic avenue for inflammatory and autoimmune diseases.
- Further research into secreted Cathepsin S functions may reveal new therapeutic strategies.